Hervé Lebrec, PharmD, PhD, DABT

VP Development Sciences
Sonoma Biotherapeutics
Alameda, California, United States

Disclosure information not submitted.

Presentation(s):

• SBT115301, a Second Generation CD2-targeting LFA3 Fusion Protein to Restore Immune Homeostasis in Autoimmune Disease

  Thursday, June 26, 2025
  5:40pm - 5:55pm East Coast USA Time